HER2-positive breast cancer with brain metastasis, long responder to lapatinib therapy
We report the case of a 45-year-old patient diagnosed, after four years from the initial diagnosis of infiltrating ductal carcinoma, with lymph node, hepatic, pulmonary and bone diseases deriving from HER2-positive breast cancer. While the association docetaxel + trastuzumab led to a partial respons...
| Príomhchruthaitheoir: | |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
AboutScience Srl
2018-06-01
|
| Sraith: | AboutOpen |
| Ábhair: | |
| Rochtain ar líne: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/160 |